Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking.
paper
Cited
Public
Unavailable
- Authors
- Steensland, Pia; Simms, Jeffrey A; Holgate, Joan; Richards, Jemma K; Bartlett, Selena E
- Year
- 2007
- Journal
- Proceedings of the National Academy of Sciences of the United States of America
- PMID
- 17626178
- DOI
- 10.1073/pnas.0705368104
- PMCID
- PMC1914040
Alcohol dependence is a disease that impacts millions of individuals worldwide. There has been some progress with pharmacotherapy for alcohol-dependent individuals; however, there remains a critical need for the development of novel and additional therapeutic approaches. Alcohol and nicotine are commonly abused together, and there is evidence that neuronal nicotinic acetylcholine receptors (nAChRs) play a role in both alcohol and nicotine dependence. Varenicline, a partial agonist at the alpha4beta2 nAChRs, reduces nicotine intake and was recently approved as a smoking cessation aid. We have investigated the role of varenicline in the modulation of ethanol consumption and seeking using three different animal models of drinking. We show that acute administration of varenicline, in doses reported to reduce nicotine reward, selectively reduced ethanol but not sucrose seeking using an operant self-administration drinking paradigm and also decreased voluntary ethanol but not water consumption in animals chronically exposed to ethanol for 2 months before varenicline treatment. Furthermore, chronic varenicline administration decreased ethanol consumption, which did not result in a rebound increase in ethanol intake when the varenicline was no longer administered. The data suggest that the alpha4beta2 nAChRs may play a role in ethanol-seeking behaviors in animals chronically exposed to ethanol. The selectivity of varenicline in decreasing ethanol consumption combined with its reported safety profile and mild side effects in humans suggest that varenicline may prove to be a treatment for alcohol dependence.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Chronic alcohol consumption and abstinence disrupt cholinergic gene expression in the mesopontine tegmentum of alcohol-preferring iP rats. | Vaidya SP et al. | β | 2026 | β |
| Metabolomic and biochemical evaluation of linalool and methyl eugenol as natural alternatives to varenicline in nicotine-induced metabolic dysfunction. | Gondal M et al. | β | 2026 | β |
| The Acetylcholine Esterase Inhibitor Donepezil Increases Dopamine Levels in the Nucleus Accumbens and Blocks the Alcohol Deprivation Effect in Rats. | LoftΓ©n A et al. | β | 2026 | β |
| A systematic review on the anti-microbial activities and structure-activity relationship (SAR) of quinoxaline derivatives. | Bellapukonda SM et al. | β | 2025 | β |
| Ketone Supplements and Alcohol-Related Responses in Rodents. | Witley S et al. | β | 2025 | β |
| Melanin-Concentrating Hormone (MCH): Role in Mediating Reward-Motivated and Emotional Behavior and the Behavioral Disturbances Produced by Repeated Exposure to Reward Substances. | Karatayev O et al. | β | 2025 | β |
| Sex- and age-dependent impacts of nicotine and ethanol binge drinking on the brain: Insights from preclinical research. | Farias Cardozo SJ et al. | β | 2025 | β |
| Alcohol and the dopamine system. | SΓΆderpalm B et al. | β | 2024 | β |
| A randomized, double-blind, placebo-controlled, multicentre trial on the efficacy of varenicline and bupropion in combination and alone for treatment of alcohol use disorder: Protocol for the COMB study. | de Bejczy A et al. | β | 2024 | β |
| Cholinergic mu-opioid receptor deletion alters reward preference and aversion-resistance. | Beane CR et al. | β | 2024 | β |
| Mecamylamine Reverses the Effects of Cytisine on the Oral Self-administration of Ethanol in Rats. | Jimenez JC et al. | β | 2024 | β |
| Prospective Association Between Tobacco Use and at-Risk Alcohol Consumption Among Swedish Adolescents: Outlining the Influence of Tobacco Product, Frequency of Use and Gender in the LoRDIA Cohort. | Andersson J et al. | β | 2024 | β |
| The Fetal Alcohol Spectrum Disorders-An Overview of Experimental Models, Therapeutic Strategies, and Future Research Directions. | KrΓ³l M et al. | β | 2024 | β |
| The GlyT1-inhibitor Org 24598 facilitates the alcohol deprivation abolishing and dopamine elevating effects of bupropionβ+βvarenicline in rats. | Olsson Y et al. | β | 2024 | β |
| Antismoking agents do not contribute synergistically to semaglutide's ability to reduce alcohol intake in rats. | AranΓ€s C et al. | β | 2023 | β |
| Cholinergic mu-opioid receptor deletion alters reward preference and aversion-resistance | Beane CR et al. | β | 2023 | β |
| Fasudil may alleviate alcohol-induced astrocyte damage by modifying lipid metabolism, as determined by metabonomics analysis. | Zhao H et al. | β | 2023 | β |
| Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective. | StokΕosa I et al. | β | 2023 | β |
| Nicotinic and muscarinic acetylcholine receptor antagonism dose-dependently decreases sign- but not goal-tracking behavior in male rats. | Gheidi A et al. | β | 2023 | β |
| Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the Ξ±4Ξ²2 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine. | Quintanilla ME et al. | β | 2023 | β |
| Role of Ξ±6-Nicotinic Receptors in Alcohol-Induced GABAergic Synaptic Transmission and Plasticity to Cholinergic Interneurons in the Nucleus Accumbens. | Wadsworth HA et al. | β | 2023 | β |
| The role of nicotinic receptors in alcohol consumption. | Kamens HM et al. | β | 2023 | β |
| Desformylflustrabromine (dFBr), a positive allosteric modulator of Ξ±4Ξ²2 nicotinic acetylcholine receptors decreases voluntary ethanol consumption and preference in male and female Sprague-Dawley rats. | Decker S et al. | β | 2022 | β |
| Heterogeneous network propagation with forward similarity integration to enhance drug-target association prediction. | Tangmanussukum P et al. | β | 2022 | β |
| Neurobiological Mechanisms of Nicotine Reward and Aversion. | Wills L et al. | β | 2022 | β |
| Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder. | Burnette EM et al. | β | 2022 | β |
| Specificity of Varenicline in Blocking Mesolimbic Circuit Activation to Natural and Drug Rewards. | Goldstein N et al. | β | 2022 | β |
| UFR2709, an Antagonist of Nicotinic Acetylcholine Receptors, Delays the Acquisition and Reduces Long-Term Ethanol Intake in Alcohol-Preferring UChB Bibulous Rats. | GΓ‘lvez G et al. | β | 2022 | β |
| An acetylcholine-dopamine interaction in the nucleus accumbens and its involvement in ethanol's dopamine-releasing effect. | LoftΓ©n A et al. | β | 2021 | β |
| Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine-A. | Touchette JC et al. | β | 2021 | β |
| Ethanol interaction with Ξ±3Ξ²4 nicotinic acetylcholine receptors in neurons of the laterodorsal tegmentum. | Abburi C et al. | β | 2021 | β |
| Investigating the effects of chronic perinatal alcohol and combined nicotine and alcohol exposure on dopaminergic and non-dopaminergic neurons in the VTA. | Kazemi T et al. | β | 2021 | β |
| The monoamine stabilizer OSU6162 has anxiolytic-like properties and reduces voluntary alcohol intake in a genetic rat model of depression. | Melas PA et al. | β | 2021 | β |
| Viral-Mediated Knockdown of Nucleus Accumbens Shell PAC1 Receptor Promotes Excessive Alcohol Drinking in Alcohol-Preferring Rats. | Minnig MA et al. | β | 2021 | β |
| An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study. | Fucito LM et al. | β | 2020 | β |
| A novel human laboratory model for screening medications for alcohol use disorder. | Ho D et al. | β | 2020 | β |
| Combined administration of varenicline and bupropion produces additive effects on accumbal dopamine and abolishes the alcohol deprivation effect in rats. | SΓΆderpalm B et al. | β | 2020 | β |
| Development of a novel alcohol and nicotine concurrent access (ANCA) self-administration procedure in baboons. | Holtyn AF et al. | β | 2020 | β |
| Different dopamine tone in ethanol high- and low-consuming Wistar rats. | Ericson M et al. | β | 2020 | β |
| Effects of ethanol, naltrexone, nicotine and varenicline in an ethanol and nicotine co-use model in Sprague-Dawley rats. | Chandler CM et al. | β | 2020 | β |
| Neurochemical Evidence of Preclinical and Clinical Reports on Target-Based Therapy in Alcohol Used Disorder. | Prajapati SK et al. | β | 2020 | β |
| Probing the Manipulated Neurochemical Drive in Alcohol Addiction and Novel Therapeutic Advancements. | Chouhan D et al. | β | 2020 | β |
| Promoting activity of (Ξ±4)<sub>3</sub>(Ξ²2)<sub>2</sub> nicotinic cholinergic receptors reduces ethanol consumption. | Wang J et al. | β | 2020 | β |
| Reduced expression of ethanol sensitization by Ξ±3Ξ²4 nicotinic acetylcholine receptors in DBA/2J mice. | Miller CN et al. | β | 2020 | β |
| The role of nicotinic acetylcholine receptors in alcohol-related behaviors. | Miller CN et al. | β | 2020 | β |
| Treating Alcohol Use Disorder in Chronic Liver Disease. | Yoo ER et al. | β | 2020 | β |
| Animal models of binge drinking, current challenges to improve face validity. | Jeanblanc J et al. | β | 2019 | β |
| Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future. | Cannella N et al. | β | 2019 | β |
| Efficacy of Varenicline in Patients With Severe Alcohol Dependence: A Pilot Double-Blind Randomized and Controlled Study. | Pfeifer P et al. | β | 2019 | β |
| Function and Mechanism of Myelin Regulation in Alcohol Abuse and Alcoholism. | Rice J et al. | β | 2019 | β |
| Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission. | Peng C et al. | β | 2019 | β |
| Modulation of serotonin and noradrenaline in the BLA by pindolol reduces long-term ethanol intake. | Patkar OL et al. | β | 2019 | β |
| Prolonged exposure of rats to varenicline increases anxiety and alters serotonergic system, but has no effect on memory. | Zaccarelli-MagalhΓ£es J et al. | β | 2019 | β |
| Therapeutic challenges for concurrent ethanol and nicotine consumption: naltrexone and varenicline fail to alter simultaneous ethanol and nicotine intake by female alcohol-preferring (P) rats. | Waeiss RA et al. | β | 2019 | β |
| UFR2709, a Nicotinic Acetylcholine Receptor Antagonist, Decreases Ethanol Intake in Alcohol-Preferring Rats. | Quiroz G et al. | β | 2019 | β |
| A Critical Review of Methods and Results in the Search for Genetic Contributors to Alcohol Sensitivity. | Schuckit MA | β | 2018 | β |
| Advancing Pharmacotherapy Development from Preclinical Animal Studies. | Egli M | β | 2018 | β |
| An improved model of ethanol and nicotine co-use in female P rats: Effects of naltrexone, varenicline, and the selective nicotinic Ξ±6Ξ²2* antagonist r-bPiDI. | Maggio SE et al. | β | 2018 | β |
| Changes in Alcohol Consumption During a Stop-Smoking Attempt and Differences Between Smokers Using Nicotine Replacement and Smokers Using Varenicline. | Przulj D et al. | β | 2018 | β |
| Differential regulation of alcohol taking and seeking by antagonism at Ξ±4Ξ²2 and Ξ±3Ξ²4 nAChRs. | Cippitelli A et al. | β | 2018 | β |
| Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial. | O'Malley SS et al. | β | 2018 | β |
| Effects of Long-Term Alcohol Drinking on the Dopamine D2 Receptor: Gene Expression and Heteroreceptor Complexes in the Striatum in Rats. | Feltmann K et al. | β | 2018 | β |
| Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats. | Maggio SE et al. | β | 2018 | β |
| Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes. | Roberts W et al. | β | 2018 | β |
| Emerging role for the medial prefrontal cortex in alcohol-seeking behaviors. | Klenowski PM | β | 2018 | β |
| Muscarinic M<sub>5</sub> receptors modulate ethanol seeking in rats. | Berizzi AE et al. | β | 2018 | β |
| New steps for treating alcohol use disorder. | Campbell EJ et al. | β | 2018 | β |
| Nicotine as a discriminative stimulus for ethanol use. | Ginsburg BC et al. | β | 2018 | β |
| Pharmacological treatments for opiate and alcohol addiction: A historical perspective of the last 50 years. | Blanco-GandΓa MC et al. | β | 2018 | β |
| Pre-conceptional and Peri-Gestational Maternal Binge Alcohol Drinking Produces Inheritance of Mood Disturbances and Alcohol Vulnerability in the Adolescent Offspring. | Brancato A et al. | β | 2018 | β |
| Sex Specific Alterations in Ξ±4*Nicotinic Receptor Expression in the Nucleus Accumbens. | Holgate JY et al. | β | 2018 | β |
| The Effects of Long-Term Varenicline Administration on Ethanol and Sucrose Seeking and Self-Administration in Male P Rats. | Czachowski CL et al. | β | 2018 | β |
| The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption. | Touchette JC et al. | β | 2018 | β |
| Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats. | Kangiser MM et al. | β | 2018 | β |
| Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial. | Hurt RT et al. | β | 2018 | β |
| Varenicline modulates ethanol and saccharin consumption in adolescent male and female C57BL/6J mice. | Kamens HM et al. | β | 2018 | β |
| Ξ±5 nAChR modulation of the prefrontal cortex makes attention resilient. | Howe WM et al. | β | 2018 | β |
| A Combination of NaltrexoneΒ +Β Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking. | Froehlich JC et al. | β | 2017 | β |
| Acute Ethanol Administration Upregulates Synaptic Ξ±4-Subunit of Neuronal Nicotinic Acetylcholine Receptors within the Nucleus Accumbens and Amygdala. | Tarren JR et al. | β | 2017 | β |
| An assessment of the utilization of the preclinical rodent model literature in clinical trials of putative therapeutics for the treatment of alcohol use disorders. | Barajaz AM et al. | β | 2017 | β |
| A Rat Drinking in the Dark Model for Studying Ethanol and Sucrose Consumption. | Holgate JY et al. | β | 2017 | β |
| Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol-induced reward in rodents. | VallΓΆf D et al. | β | 2017 | β |
| Effects of varenicline on alcohol cue reactivity in heavy drinkers. | Roberts W et al. | β | 2017 | β |
| Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms. | Roberts W et al. | β | 2017 | β |
| Interactions between nicotine and drugs of abuse: a review of preclinical findings. | Kohut SJ | β | 2017 | β |
| Intermittent Access to Ethanol Induces Escalated Alcohol Consumption in Primates. | Lindell SG et al. | β | 2017 | β |
| Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. | Yardley MM et al. | β | 2017 | β |
| Nicotine-induced enhancement of Pavlovian alcohol-seeking behavior in rats. | Maddux JN et al. | β | 2017 | β |
| Preclinical development of moxidectin as a novel therapeutic for alcohol use disorder. | Huynh N et al. | β | 2017 | β |
| The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target? | Pomrenze MB et al. | β | 2017 | β |
| The Glycine Receptor-A Functionally Important Primary Brain Target of Ethanol. | SΓΆderpalm B et al. | β | 2017 | β |
| Varenicline Reduces Alcohol Intake During Repeated Cycles of Alcohol Reaccess Following Deprivation in Alcohol-Preferring (P) Rats. | Froehlich JC et al. | β | 2017 | β |
| Varenicline Reduces Context-Induced Relapse to Alcohol-Seeking through Actions in the Nucleus Accumbens. | Lacroix F et al. | β | 2017 | β |
| Ξ±6Ξ²2 nicotinic acetylcholine receptors influence locomotor activity and ethanol consumption. | Kamens HM et al. | β | 2017 | β |
| Acquisition and reinstatement of ethanol-induced conditioned place preference in rats: Effects of the cholinesterase inhibitors donepezil and rivastigmine. | Gawel K et al. | β | 2016 | β |
| A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction. | Bell RL et al. | β | 2016 | β |
| A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration. | Cippitelli A et al. | β | 2016 | β |
| Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users? | Kleczkowska P et al. | β | 2016 | β |
| Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism. | Froehlich JC et al. | β | 2016 | β |
| Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse. | Van Skike CE et al. | β | 2016 | β |
| Different Hypothalamic Nicotinic Ξ±7 Receptor Expression and Response to Low Nicotine Dose in Alcohol-Preferring and Alcohol-Avoiding Rats. | Nuutinen S et al. | β | 2016 | β |
| Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders. | Verplaetse TL et al. | β | 2016 | β |
| Effect of Varenicline Combined with High-Dose Alcohol on Craving, Subjective Intoxication, Perceptual Motor Response, and Executive Cognitive Function in Adults with Alcohol Use Disorders: Preliminary Findings. | Verplaetse TL et al. | β | 2016 | β |
| Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse. | Funk D et al. | β | 2016 | β |
| Increased Synaptic Excitation and Abnormal Dendritic Structure of Prefrontal Cortex Layer V Pyramidal Neurons following Prolonged Binge-Like Consumption of Ethanol. | Klenowski PM et al. | β | 2016 | β |
| Neuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake. | Shariff M et al. | β | 2016 | β |
| Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety. | Litten RZ et al. | β | 2016 | β |
| Prenatal fat exposure and hypothalamic PPAR Ξ²/Ξ΄: Possible relationship to increased neurogenesis of orexigenic peptide neurons. | Chang GQ et al. | β | 2016 | β |
| Prolonged Consumption of Sucrose in a Binge-Like Manner, Alters the Morphology of Medium Spiny Neurons in the Nucleus Accumbens Shell. | Klenowski PM et al. | β | 2016 | β |
| Recent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism. | Rahman S et al. | β | 2016 | β |
| Recruitment of a Neuronal Ensemble in the Central Nucleus of the Amygdala Is Required for Alcohol Dependence. | de Guglielmo G et al. | β | 2016 | β |
| Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research. | Fritz BM et al. | β | 2016 | β |
| The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation. | Warnault V et al. | β | 2016 | β |
| The effect of varenicline on binge-like ethanol consumption in mice is Ξ²4 nicotinic acetylcholine receptor-independent. | Patkar OL et al. | β | 2016 | β |
| The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers. | Gowin JL et al. | β | 2016 | β |
| The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats. | Pittenger ST et al. | β | 2016 | β |
| The monoamine stabilizer (-)-OSU6162 counteracts downregulated dopamine output in the nucleus accumbens of long-term drinking Wistar rats. | Feltmann K et al. | β | 2016 | β |
| The Nicotinic Ξ±6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats. | Srisontiyakul J et al. | β | 2016 | β |
| AT-1001: a high-affinity Ξ±3Ξ²4 nAChR ligand with novel nicotine-suppressive pharmacology. | Cippitelli A et al. | β | 2015 | β |
| Early Life Stress, Nicotinic Acetylcholine Receptors and Alcohol Use Disorders. | Holgate JY et al. | β | 2015 | β |
| Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers. | Vatsalya V et al. | β | 2015 | β |
| Ethanol-Induced Cerebellar Ataxia: Cellular and Molecular Mechanisms. | Dar MS | β | 2015 | β |
| Evaluation of guanfacine as a potential medication for alcohol use disorder in long-term drinking rats: behavioral and electrophysiological findings. | Fredriksson I et al. | β | 2015 | β |
| Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis. | Falk DE et al. | β | 2015 | β |
| Nicotine administration in the wake-promoting basal forebrain attenuates sleep-promoting effects of alcohol. | Sharma R et al. | β | 2015 | β |
| Nicotine and ethanol cooperate to enhance ventral tegmental area AMPA receptor function via Ξ±6-containing nicotinic receptors. | Engle SE et al. | β | 2015 | β |
| Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. | Yardley MM et al. | β | 2015 | β |
| Postdependent state in rats as a model for medication development in alcoholism. | Meinhardt MW et al. | β | 2015 | β |
| Reward Anticipation Is Differentially Modulated by Varenicline and Nicotine in Smokers. | Fedota JR et al. | β | 2015 | β |
| Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats. | Blasio A et al. | β | 2015 | β |
| The role of varenicline on alcohol-primed self-administration and seeking behavior in rats. | Randall PA et al. | β | 2015 | β |
| Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats. | Scuppa G et al. | β | 2015 | β |
| Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial. | de Bejczy A et al. | β | 2015 | β |
| Alcohol: mechanisms along the mesolimbic dopamine system. | Engel JA et al. | β | 2014 | β |
| Association of the CHRNA4 neuronal nicotinic receptor subunit gene with frequency of binge drinking in young adults. | Coon H et al. | β | 2014 | β |
| Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders. | Asatryan L et al. | β | 2014 | β |
| Brucine suppresses ethanol intake and preference in alcohol-preferring Fawn-Hooded rats. | Li YL et al. | β | 2014 | β |
| Drug effects on multiple and concurrent schedules of ethanol- and food-maintained behaviour: context-dependent selectivity. | Ginsburg BC et al. | β | 2014 | β |
| Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization. | Gubner NR et al. | β | 2014 | β |
| Enhanced alcohol-seeking behavior by nicotine in the posterior ventral tegmental area of female alcohol-preferring (P) rats: modulation by serotonin-3 and nicotinic cholinergic receptors. | Hauser SR et al. | β | 2014 | β |
| Future pharmacological treatments for substance use disorders. | Forray A et al. | β | 2014 | β |
| "Killing Two Birds with One Stone": Alcohol Use Reduction Interventions with Potential Efficacy in Enhancing Self-Control. | Leeman RF et al. | β | 2014 | β |
| MiR-153 targets the nuclear factor-1 family and protects against teratogenic effects of ethanol exposure in fetal neural stem cells. | Tsai PC et al. | β | 2014 | β |
| Nicotine administration in the cholinergic basal forebrain increases alcohol consumption in C57BL/6J mice. | Sharma R et al. | β | 2014 | β |
| Nicotine infusion in the wake-promoting basal forebrain enhances alcohol-induced activation of nucleus accumbens. | Sharma R et al. | β | 2014 | β |
| Nicotinic receptor modulation to treat alcohol and drug dependence. | Rahman S et al. | β | 2014 | β |
| Operant self-administration of alcohol and nicotine in a preclinical model of co-abuse. | LΓͺ AD et al. | β | 2014 | β |
| P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders. | Franklin KM et al. | β | 2014 | β |
| Peripherally circulating ghrelin does not mediate alcohol-induced reward and alcohol intake in rodents. | Jerlhag E et al. | β | 2014 | β |
| Pharmacological approaches to reducing craving in patients with alcohol use disorders. | Haass-Koffler CL et al. | β | 2014 | β |
| Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependence. | Haller G et al. | β | 2014 | β |
| Relative potency of varenicline or fluvoxamine to reduce responding for ethanol versus food depends on the presence or absence of concurrently earned food. | Ginsburg BC et al. | β | 2014 | β |
| Rodent models for compulsive alcohol intake. | Hopf FW et al. | β | 2014 | β |
| Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapy. | Engel JA et al. | β | 2014 | β |
| The effects of varenicline on alcohol seeking and self-administration in baboons. | Kaminski BJ et al. | β | 2014 | β |
| The role of the habenula in drug addiction. | Velasquez KM et al. | β | 2014 | β |
| Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens. | Feduccia AA et al. | β | 2014 | β |
| Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals. | Schacht JP et al. | β | 2014 | β |
| Varenicline in the treatment of alcohol use disorders. | Erwin BL et al. | β | 2014 | β |
| Varenicline is more effective in attenuating weight gain than nicotine patch 12 months after the end of smoking cessation therapy: an observational study in Japan. | Taniguchi C et al. | β | 2014 | β |
| A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. | Litten RZ et al. | β | 2013 | β |
| Chemistry and pharmacological studies of 3-alkoxy-2,5-disubstituted-pyridinyl compounds as novel selective Ξ±4Ξ²2 nicotinic acetylcholine receptor ligands that reduce alcohol intake in rats. | Liu Y et al. | β | 2013 | β |
| Chromatin remodeling--a novel strategy to control excessive alcohol drinking. | Warnault V et al. | β | 2013 | β |
| Cytisine modulates chronic voluntary ethanol consumption and ethanol-induced striatal up-regulation of ΞFosB in mice. | Sajja RK et al. | β | 2013 | β |
| Effects of varenicline on ethanol- and food-maintained responding in a concurrent access procedure. | Ginsburg BC et al. | β | 2013 | β |
| Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. | Suchankova P et al. | β | 2013 | β |
| How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use? | McKee SA et al. | β | 2013 | β |
| Involvement of dorsal hippocampal and medial septal nicotinic receptors in cross state-dependent memory between WIN55, 212-2 and nicotine or ethanol in mice. | Alijanpour S et al. | β | 2013 | β |
| Longitudinal associations between smoking cessation medications and alcohol consumption among smokers in the International Tobacco Control Four Country survey. | McKee SA et al. | β | 2013 | β |
| Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. | Hendrickson LM et al. | β | 2013 | β |
| Nicotinic acetylcholine receptors containing the Ξ±4 subunit modulate alcohol reward. | Liu L et al. | β | 2013 | β |
| Nicotinic acetylcholine receptors containing the Ξ±6 subunit contribute to ethanol activation of ventral tegmental area dopaminergic neurons. | Liu L et al. | β | 2013 | β |
| Nicotinic acetylcholine receptors: from basic science to therapeutics. | Hurst R et al. | β | 2013 | β |
| Nicotinic receptor partial agonists modulate alcohol deprivation effect in C57BL/6J mice. | Sajja RK et al. | β | 2013 | β |
| Pharmacotherapy for alcohol dependence: status of current treatments. | Franck J et al. | β | 2013 | β |
| Potential substrates for nicotine and alcohol interactions: a focus on the mesocorticolimbic dopamine system. | Doyon WM et al. | β | 2013 | β |
| Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders. | Davies DL et al. | β | 2013 | β |
| Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence. | Plebani JG et al. | β | 2013 | β |
| The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents. | Egecioglu E et al. | β | 2013 | β |
| The Ξ±5 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice. | Santos N et al. | β | 2013 | β |
| The Ξ²2 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse. | Dawson A et al. | β | 2013 | β |
| Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats. | Sotomayor-ZΓ‘rate R et al. | β | 2013 | β |
| Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction? | Nocente R et al. | β | 2013 | β |
| Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum/diagonal band neurons. | DuBois DW et al. | β | 2013 | β |
| Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial. | Meszaros ZS et al. | β | 2013 | β |
| Alpha4 subunit-containing GABAA receptors in the accumbens shell contribute to the reinforcing effects of alcohol. | Rewal M et al. | β | 2012 | β |
| Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats. | Johnson JE et al. | β | 2012 | β |
| Ghrelin receptor (GHS-R1A) antagonism suppresses both operant alcohol self-administration and high alcohol consumption in rats. | Landgren S et al. | β | 2012 | β |
| Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations. | Drenan RM et al. | β | 2012 | β |
| Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice. | Kruk-SΕomka M et al. | β | 2012 | β |
| Ivermectin reduces alcohol intake and preference in mice. | Yardley MM et al. | β | 2012 | β |
| Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictions. | Feduccia AA et al. | β | 2012 | β |
| Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL/6J mice. | Sajja RK et al. | β | 2012 | β |
| Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation. | Addolorato G et al. | β | 2012 | β |
| Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review. | Hurley LL et al. | β | 2012 | β |
| Preliminary findings on the interactive effects of IV ethanol and IV nicotine on human behavior and cognition: a laboratory study. | Ralevski E et al. | β | 2012 | β |
| Reward and relapse: complete gene-induced dissociation in an animal model of alcohol dependence. | Quintanilla ME et al. | β | 2012 | β |
| The CHRNA5-A3-B4 gene cluster in nicotine addiction. | Berrettini WH et al. | β | 2012 | β |
| The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking. | Nielsen CK et al. | β | 2012 | β |
| The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens. | Steensland P et al. | β | 2012 | β |
| The neurobiology of binge-like ethanol drinking: evidence from rodent models. | Sprow GM et al. | β | 2012 | β |
| The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats. | Wen RT et al. | β | 2012 | β |
| Varenicline decreases alcohol consumption in heavy-drinking smokers. | Mitchell JM et al. | β | 2012 | β |
| Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements. | Childs E et al. | β | 2012 | β |
| Alcohol research: past, present, and future. | Gunzerath L et al. | β | 2011 | β |
| A preliminary investigation of varenicline for heavy drinking smokers. | Fucito LM et al. | β | 2011 | β |
| Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. | Gould RW et al. | β | 2011 | β |
| Induction of multiple reinstatements of ethanol- and sucrose-seeking behavior in Long-Evans rats by the Ξ±-2 adrenoreceptor antagonist yohimbine. | Simms JA et al. | β | 2011 | β |
| Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL/6J mice. | Sajja RK et al. | β | 2011 | β |
| Low frequency electroacupuncture selectively decreases voluntarily ethanol intake in rats. | Li J et al. | β | 2011 | β |
| Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence. | Cosgrove KP et al. | β | 2011 | β |
| Nicotinic acetylcholine receptors containing the Ξ±4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption. | Hendrickson LM et al. | β | 2011 | β |
| Partial agonists of the Ξ±3Ξ²4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. | Chatterjee S et al. | β | 2011 | β |
| Recent advances in gene manipulation and nicotinic acetylcholine receptor biology. | TammimΓ€ki A et al. | β | 2011 | β |
| Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. | Tuesta LM et al. | β | 2011 | β |
| Role of Ξ±6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders. | Quik M et al. | β | 2011 | β |
| Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking. | Walker N et al. | β | 2011 | β |
| Temporal sequence of incident cigarette, coffee, and alcohol use among AA participants. | Reich MS et al. | β | 2011 | β |
| The ghrelin signalling system is involved in the consumption of sweets. | Landgren S et al. | β | 2011 | β |
| The role of nicotinic acetylcholine receptor (nAChR) Ξ±7 subtype in the functional interaction between nicotine and ethanol in mouse cerebellum. | Taslim N et al. | β | 2011 | β |
| The Role of the Habenula in Nicotine Addiction. | Baldwin PR et al. | β | 2011 | β |
| Translational research in addiction: toward a framework for the development of novel therapeutics. | Paterson NE | β | 2011 | β |
| Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats. | Bito-Onon JJ et al. | β | 2011 | β |
| Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control. | Wouda JA et al. | β | 2011 | β |
| Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption. | Hendrickson LM et al. | β | 2010 | β |
| Activators of G-protein signaling 3: a drug addiction molecular gateway. | Bowers MS | β | 2010 | β |
| Delineation of the role of nicotinic acetylcholine receptor genes in alcohol preference in mice. | Symons MN et al. | β | 2010 | β |
| Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats. | Rezvani AH et al. | β | 2010 | β |
| Effects of systemic nicotine, alcohol or their combination on cholinergic markers in the frontal cortex and hippocampus of rat. | Jamal M et al. | β | 2010 | β |
| Genetic variation and brain gene expression in rodent models of alcoholism implications for medication development. | BjΓΆrk K et al. | β | 2010 | β |
| Long-Evans rats acquire operant self-administration of 20% ethanol without sucrose fading. | Simms JA et al. | β | 2010 | β |
| Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice. | Kamens HM et al. | β | 2010 | β |
| Motivation for alcohol becomes resistant to quinine adulteration after 3 to 4 months of intermittent alcohol self-administration. | Hopf FW et al. | β | 2010 | β |
| Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. | Chatterjee S et al. | β | 2010 | β |
| New horizons for therapeutics in drug and alcohol abuse. | Jupp B et al. | β | 2010 | β |
| Something must be done! But is Moore correct that something can be worse than nothing in alcohol control policy? | Humphreys K | β | 2010 | β |
| SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individuals. | Esterlis I et al. | β | 2010 | β |
| The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. | O'Connor EC et al. | β | 2010 | β |
| The neurokinin 1 receptor antagonist, ezlopitant, reduces appetitive responding for sucrose and ethanol. | Steensland P et al. | β | 2010 | β |
| The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review. | Crunelle CL et al. | β | 2010 | β |
| The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. | Kamens HM et al. | β | 2010 | β |
| The Treatment of Obesity and Its Co-occurrence with Substance Use Disorders. | Vanbuskirk KA et al. | β | 2010 | β |
| Varenicline effects on cocaine self administration and reinstatement behavior. | Guillem K et al. | β | 2010 | β |
| Alcoholism: a systems approach from molecular physiology to addictive behavior. | Spanagel R | β | 2009 | β |
| Alcohol-use disorders. | Schuckit MA | β | 2009 | β |
| Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. | Tizabi Y et al. | β | 2009 | β |
| Association of nAChR gene haplotypes with heavy alcohol use and body mass. | Landgren S et al. | β | 2009 | β |
| Cabergoline decreases alcohol drinking and seeking behaviors via glial cell line-derived neurotrophic factor. | Carnicella S et al. | β | 2009 | β |
| Effects of subunit selective nACh receptors on operant ethanol self-administration and relapse-like ethanol-drinking behavior. | Kuzmin A et al. | β | 2009 | β |
| Emerging drugs for the treatment of tobacco dependence. | Ebbert JO | β | 2009 | β |
| Happyhour, a Ste20 family kinase, implicates EGFR signaling in ethanol-induced behaviors. | Corl AB et al. | β | 2009 | β |
| Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? | Arias HR | β | 2009 | β |
| Loop 2 structure in glycine and GABA(A) receptors plays a key role in determining ethanol sensitivity. | Perkins DI et al. | β | 2009 | β |
| Mechanism-based medication development for the treatment of nicotine dependence. | Xi ZX et al. | β | 2009 | β |
| Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice. | Hendrickson LM et al. | β | 2009 | β |
| Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study. | King A et al. | β | 2009 | β |
| New insights into the genetics of addiction. | Li MD et al. | β | 2009 | β |
| Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats. | Bell RL et al. | β | 2009 | β |
| Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. | Rollema H et al. | β | 2009 | β |
| Recent advances in understanding the structure of nicotinic acetylcholine receptors. | Zouridakis M et al. | β | 2009 | β |
| SNPs in CHRNA6 and CHRNB3 are associated with alcohol consumption in a nationally representative sample. | Hoft NR et al. | β | 2009 | β |
| Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes. | Tasso B et al. | β | 2009 | β |
| The influence of mecamylamine on ethanol and sucrose self-administration. | Ford MM et al. | β | 2009 | β |
| The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system. | Ericson M et al. | β | 2009 | β |
| Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats. | Spiller K et al. | β | 2009 | β |
| Varenicline for smoking cessation: A review of the literature. | Kaur K et al. | β | 2009 | β |
| Varenicline reduces alcohol self-administration in heavy-drinking smokers. | McKee SA et al. | β | 2009 | β |
| Addiction: the clinical interface. | Nutt D et al. | β | 2008 | β |
| A novel delta opioid receptor antagonist, SoRI-9409, produces a selective and long-lasting decrease in ethanol consumption in heavy-drinking rats. | Nielsen CK et al. | β | 2008 | β |
| Attenuation of ethanol-induced ataxia by alpha(4)beta(2) nicotinic acetylcholine receptor subtype in mouse cerebellum: a functional interaction. | Taslim N et al. | β | 2008 | β |
| Chromosome 15q25.1 genetic markers associated with level of response to alcohol in humans. | Joslyn G et al. | β | 2008 | β |
| Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats. | Zaniewska M et al. | β | 2008 | β |
| Endogenous opiates and behavior: 2007. | Bodnar RJ | β | 2008 | β |
| Fifty years of Biochemical Pharmacology: the discipline and the journal. | Enna SJ et al. | β | 2008 | β |
| GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. | Carnicella S et al. | β | 2008 | β |
| Identification of Quantitative Trait Loci and candidate genes influencing ethanol sensitivity in honey bees. | Ammons AD et al. | β | 2008 | β |
| Making a bad thing worse: adverse effects of stress on drug addiction. | Cleck JN et al. | β | 2008 | β |
| Nicotinic receptors, allosteric proteins and medicine. | Changeux JP et al. | β | 2008 | β |
| Nucleus accumbens AGS3 expression drives ethanol seeking through G betagamma. | Bowers MS et al. | β | 2008 | β |
| Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development? | Wallner M et al. | β | 2008 | β |
| Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. | Fowler CD et al. | β | 2008 | β |
| Targets for ethanol action and antagonism in loop 2 of the extracellular domain of glycine receptors. | Perkins DI et al. | β | 2008 | β |
| Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism. | Krishnan-Sarin S et al. | β | 2008 | β |
| Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice. | Gulick D et al. | β | 2008 | β |
| Varenicline and its role in smoking cessation. | Kapoor S | β | 2008 | β |
| Voluntary ethanol intake enhances excitatory synaptic strength in the ventral tegmental area. | Stuber GD et al. | β | 2008 | β |
| Neuronal nicotinic receptors: a perspective on two decades of drug discovery research. | Arneric SP et al. | β | 2007 | β |